Flu A vs Flu B: Symptoms, Differences & Treatment

When comparing flu A vs flu B, it is important to understand that both are influenza viruses capable of causing seasonal respiratory illness. They can produce very similar symptoms, including fever, cough, sore throat, headache, fatigue, and body aches. However, the viruses differ in their classification, evolution, circulation patterns, and pandemic potential.

Unlike a football head-to-head comparison, influenza A and influenza B do not have wins, draws, losses, goals, or previous match results. Instead, the useful comparison involves virus type, symptoms, transmission, testing, seasonal prevalence, treatment, complications, and prevention. Therefore, this guide focuses on medically meaningful statistics and current surveillance information.

For the latest available U.S. surveillance data, CDC reported that influenza activity remained relatively low nationally but was increasing by the week ending September 26, 2026. During that week, 3.4% of respiratory specimens tested positive for influenza, with influenza A accounting for 96.3% of positive influenza detections and influenza B accounting for 3.7%.

Quick Answer

The simplest answer to flu A vs flu B is that both can cause seasonal flu and can make people seriously ill, but influenza A and influenza B are different virus types.

Feature	Influenza A	Influenza B
Virus type	Type A influenza virus	Type B influenza virus
Seasonal illness	Yes	Yes
Subtypes	Yes	No
Common human viruses	A(H1N1)pdm09, A(H3N2)	Mainly B/Victoria lineage
Pandemic potential	Known to cause influenza pandemics	Not known to cause pandemics
Can cause severe illness?	Yes	Yes
Symptoms	Very similar to influenza B	Very similar to influenza A
Testing	Can be identified by many flu tests	Can be identified by many flu tests
Vaccine protection	Included in seasonal vaccines	Included in seasonal vaccines
Current U.S. 2025–26 cumulative share	70.7% of positive clinical-lab specimens	29.3%

The last row refers specifically to CDC clinical laboratory surveillance accumulated through September 26, 2026, covering the 2025–26 season. It should not be interpreted as a permanent ratio between the two virus types.

What Are Influenza A and Influenza B?

Influenza A and influenza B are two of the four recognized types of influenza viruses: A, B, C, and D. Of these, influenza A and B are the main types responsible for seasonal flu epidemics in humans.

Influenza A is classified into subtypes according to two surface proteins called hemagglutinin and neuraminidase. The influenza A viruses currently circulating widely among humans include A(H1N1)pdm09 and A(H3N2). These names describe characteristics of the virus rather than separate diseases.

Influenza B works differently. It is not divided into the same H and N subtypes used for influenza A. Instead, influenza B viruses are classified into lineages. The World Health Organization identifies the B/Victoria lineage as the relevant circulating lineage, while B/Yamagata has not been detected in recent surveillance.

This distinction matters because the two virus types evolve differently. Consequently, surveillance programs monitor them separately even though they can cause nearly indistinguishable symptoms.

Flu A vs Flu B: Main Differences

The biggest differences between influenza A and B involve their biology and epidemiology rather than a simple difference in symptoms.

Difference	Flu A	Flu B
Classification	Subtypes	Lineages
Examples	H1N1, H3N2	B/Victoria
Known pandemic cause	Yes	No
Seasonal epidemics	Yes	Yes
Human infections	Common	Common
Symptoms	Flu-like	Flu-like
Severity	Can range from mild to severe	Can range from mild to severe
Surveillance	Separately monitored	Separately monitored

Influenza A has a broader host range than influenza B and is the only influenza type known to have caused influenza pandemics. A pandemic can occur when a sufficiently different influenza A virus emerges and spreads efficiently among people who have little immunity to it.

That does not mean every influenza A infection is more severe than influenza B. Severity depends on many factors, including the individual’s age, underlying health, immune status, the specific virus, and the timing of treatment.

Therefore, saying that “flu A is always worse than flu B” would be inaccurate.

Symptoms: Can You Tell Them Apart?

In most cases, symptoms alone cannot reliably tell you whether an infection is influenza A or influenza B.

Both types can cause a sudden respiratory illness. Common symptoms include:

• Fever
• Cough
• Sore throat
• Headache
• Muscle aches
• Joint or body pain
• Fatigue
• Weakness
• Runny or stuffy nose
• Chills

The CDC notes that flu commonly begins abruptly and that fever, body aches, fatigue, headache, and cough are characteristic symptoms. However, not everyone with influenza develops every symptom, and some people may have flu without a measured fever.

The World Health Organization similarly describes seasonal influenza as an acute respiratory infection that can cause sudden fever, cough, headache, muscle and joint pain, severe malaise, sore throat, and a runny nose.

Symptom	Flu A	Flu B
Fever	Common	Common
Cough	Common	Common
Sore throat	Possible/common	Possible/common
Body aches	Common	Common
Headache	Common	Common
Fatigue	Common	Common
Runny nose	Possible	Possible
Chills	Possible	Possible

Because the symptom profiles overlap so heavily, guessing the virus type from symptoms is unreliable.

For example, a person with a high fever and severe body aches cannot conclude that they have influenza A simply because the illness feels intense. Influenza B can also produce substantial illness.

How Testing Distinguishes Flu A From Flu B

Testing is more useful than symptoms when the specific influenza type needs to be identified.

Some rapid and molecular influenza tests can detect influenza A and influenza B separately. CDC also notes that at-home tests are available that can detect influenza A, influenza B, and SARS-CoV-2 from upper-respiratory specimens.

Different tests have different levels of sensitivity and specificity. A negative rapid test therefore does not always rule out influenza, particularly when flu is circulating and symptoms strongly suggest infection.

Healthcare professionals may use clinical judgment alongside testing. CDC explains that clinicians do not always need a positive test before treating someone for influenza, particularly when the person is at increased risk of serious complications.

A typical comparison looks like this:

Testing question	Flu A	Flu B
Can rapid tests detect it?	Yes, depending on test	Yes, depending on test
Can molecular tests identify it?	Yes	Yes
Can some home tests distinguish it?	Yes	Yes
Can symptoms alone confirm it?	No	No
Does every flu test provide the same information?	No	No

Testing becomes particularly useful when the result could affect clinical management, infection-control decisions, or diagnosis of people at higher risk.

2025–26 Season: What the Numbers Show

A useful way to compare influenza A and B is through surveillance data rather than trying to create a traditional head-to-head record.

CDC surveillance for the 2025–26 U.S. flu season recorded 3,159,585 respiratory specimens tested by clinical laboratories through the week ending September 26, 2026. Of those, 327,476 were positive for influenza. Influenza A represented 231,550 positive specimens, while influenza B represented 95,926.

2025–26 U.S. surveillance measure	Influenza A	Influenza B
Positive clinical-lab specimens	231,550	95,926
Share of positive specimens	70.7%	29.3%
Surveillance period	Sept. 28, 2025–Sept. 26, 2026	Sept. 28, 2025–Sept. 26, 2026

These are surveillance results, not individual patient counts. One person can potentially be tested more than once, and surveillance data are collected for monitoring influenza activity rather than creating a direct patient-by-patient comparison.

The balance between influenza A and B can also change during a season. For example, CDC data from the week ending June 27, 2026 showed a much closer split among positive specimens that week: 50.8% were influenza A and 49.2% were influenza B.

By late September, influenza A was again much more dominant in the weekly laboratory results. For the week ending September 26, 2026, 96.3% of positive specimens were influenza A and 3.7% were influenza B.

This illustrates why one week’s statistics should not be treated as a permanent pattern.

Current 2026 Flu Season Context

The current U.S. season is 2026–27, and CDC updated its seasonal influenza information on September 29, 2026. Vaccines for the 2026–27 season are available for people aged 6 months and older.

The vaccine composition was updated for the new season. CDC states that all three virus components of the 2026–27 U.S. seasonal flu vaccines were updated compared with the 2025–26 vaccines. The composition includes influenza A(H1N1)pdm09, influenza A(H3N2), and an influenza B/Victoria-lineage component.

This is important because influenza viruses continually evolve. Vaccine composition is therefore reviewed and updated so that vaccines better match viruses expected to circulate.

The most recent CDC surveillance report available at the time of writing covers the week ending September 26, 2026. It reported that seasonal influenza activity remained low nationally but was increasing.

Because the 2026–27 season was only beginning to develop at this point, it would be inappropriate to claim that influenza A or B will dominate the entire season. Early-season results can change substantially as transmission increases.

Transmission, Duration, and Recovery

Both influenza A and B spread through respiratory transmission and can move rapidly through communities.

People can become infected after exposure to respiratory particles released when an infected person coughs, sneezes, or otherwise spreads respiratory secretions. Transmission can also occur through contaminated hands and surfaces.

The incubation period is generally around two days, although WHO gives a range of approximately one to four days. Symptoms commonly last around a week, while cough and tiredness can persist longer.

Characteristic	Influenza A	Influenza B
Respiratory transmission	Yes	Yes
Incubation period	Usually about 2 days	Usually about 2 days
Typical illness duration	About a week for many people	About a week for many people
Cough may persist	Yes	Yes
Can cause complications	Yes	Yes

Individual recovery can vary considerably. Some people experience a relatively mild illness, whereas others develop complications requiring medical attention.

High-risk groups include young children, older adults, pregnant people, and individuals with certain chronic medical conditions or weakened immune systems.

Severity, Complications, and Who Is Most at Risk

There is no reliable rule saying that influenza A is always more dangerous than influenza B.

Both can cause serious complications. Influenza can lead to pneumonia and can worsen existing medical conditions. Severe disease is more likely in certain high-risk groups.

Potential complications include:

• Pneumonia
• Dehydration
• Worsening of chronic medical conditions
• Secondary infections
• Hospitalization
• Rarely, death

The risk is particularly important for young children, older adults, pregnant people, and people with chronic conditions affecting the heart, lungs, kidneys, metabolism, blood, or immune system.

The CDC recommends prompt medical attention for people experiencing emergency warning signs. These can include difficulty breathing, chest pain, severe weakness, dehydration, confusion, or symptoms that improve and then become worse.

Therefore, the virus label alone should not determine how seriously an illness is treated. The patient’s symptoms and risk factors matter too.

Treatment and Antiviral Options

Treatment for influenza A and influenza B is generally based on the same principles.

Many otherwise healthy people recover with supportive care, including rest, fluids, and treatment aimed at relieving symptoms. However, antiviral medications may be recommended for people at higher risk of complications or people who are very ill.

CDC says people at increased risk should contact a healthcare professional early because antiviral treatment provides the greatest benefit when started within two days of illness onset.

Importantly, antiviral treatment is not limited to influenza A. Appropriate antivirals can also be used for influenza B.

Treatment consideration	Flu A	Flu B
Rest and fluids	Common supportive care	Common supportive care
Symptom management	Yes	Yes
Antiviral treatment may be used	Yes	Yes
Early treatment important for high-risk people	Yes	Yes
Antibiotics treat the influenza virus	No	No

Antibiotics do not treat influenza because influenza is caused by a virus rather than bacteria. They may sometimes be prescribed if a bacterial complication develops, but that is a separate medical issue.

People at higher risk should not delay medical advice simply because symptoms initially appear manageable.

Prevention and the Role of Vaccination

Vaccination remains one of the most important tools for reducing the risk of influenza and its complications.

The WHO states that vaccination is the best way to prevent influenza, while CDC provides annual vaccine recommendations based on expected circulating viruses.

For the 2026–27 U.S. season, the recommended vaccine composition includes protection against influenza A(H1N1)pdm09, influenza A(H3N2), and influenza B/Victoria-lineage viruses.

Other practical prevention measures include:

• Staying home when sick
• Avoiding close contact with people who are ill
• Covering coughs and sneezes
• Washing hands regularly
• Improving ventilation where practical
• Following local public-health guidance
• Getting the recommended seasonal flu vaccine

These measures are useful because influenza can spread before people realize exactly which virus type they have.

Important Facts About Flu A vs Flu B

Here are the most useful takeaways:

• Influenza A and B are both major causes of seasonal flu.
• Influenza A is divided into subtypes such as H1N1 and H3N2.
• Influenza B is classified into lineages rather than H/N subtypes.
• Both can cause fever, cough, fatigue, headaches, and body aches.
• Symptoms alone usually cannot determine whether someone has A or B.
• Some tests can distinguish influenza A from influenza B.
• Influenza A is the only influenza type known to have caused pandemics.
• Influenza B can still cause serious illness and complications.
• Antiviral treatment can apply to both influenza A and influenza B.
• Vaccines are designed to provide protection against important circulating influenza A and B viruses.
• CDC surveillance showed influenza A predominating in the late-September 2026 U.S. data.
• Seasonal dominance can change, so one surveillance week should not be treated as a prediction for the entire season.

Frequently Asked Questions About Influenza A and B

Is flu A worse than flu B?

Not necessarily. Influenza A can cause severe disease, but influenza B can also cause serious illness. Severity depends on the virus, the individual, underlying health conditions, age, immune status, and other factors.

What is the main difference between flu A and flu B?

The main biological difference is how the viruses are classified and evolve. Influenza A is divided into subtypes such as H1N1 and H3N2, while influenza B is divided into lineages. Influenza A is also the only influenza type known to have caused pandemics.

Can you have flu A and flu B at the same time?

It is possible for a person to be infected with more than one respiratory virus, but a specific diagnosis requires appropriate testing. Symptoms alone cannot establish whether someone has one influenza type, both, or another respiratory infection.

How long does flu A last compared with flu B?

There is no simple rule that influenza A always lasts longer. WHO states that most people recover from influenza symptoms within about a week, although coughing can continue for two weeks or more.

Can a flu test tell whether I have A or B?

Some influenza tests can detect and distinguish influenza A and influenza B. Molecular tests can provide more detailed diagnostic information than some rapid antigen tests. CDC also notes that certain at-home tests can detect both influenza A and B.

Does the flu vaccine protect against both A and B?

Seasonal influenza vaccines are designed to protect against selected influenza A and B viruses expected to circulate. For the U.S. 2026–27 season, CDC lists two influenza A components and one influenza B/Victoria component in the recommended trivalent vaccines.

Which flu type is more common in 2026?

The answer depends on the exact surveillance period and location. In the most recent U.S. CDC clinical-laboratory report available at the time of writing, covering the week ending September 26, 2026, influenza A accounted for 96.3% of positive specimens and influenza B for 3.7%.

When should someone seek medical care for flu?

People at higher risk of complications should contact a healthcare professional promptly after developing flu symptoms. Emergency medical care is appropriate when serious warning signs such as difficulty breathing, chest pain, severe dehydration, confusion, or significant worsening occur.

Conclusion

The comparison of flu A vs flu B is more useful when it focuses on virology, symptoms, surveillance, testing, and health risks rather than treating the two viruses like competing teams. Both can cause seasonal influenza, both can produce similar symptoms, and both can sometimes lead to serious complications.

Influenza A differs because it is divided into subtypes and is the only influenza type known to have caused pandemics. Influenza B is classified into lineages and remains an important cause of seasonal illness. Current U.S. surveillance through September 26, 2026 showed influenza A accounting for most positive clinical-laboratory specimens, but that result represents a specific surveillance period rather than a prediction for the entire 2026–27 season.

For anyone with significant symptoms or a higher risk of complications, the most important step is not determining which type is “worse.” Prompt medical advice, appropriate testing when needed, timely antiviral treatment for eligible patients, and seasonal vaccination are more meaningful factors in reducing the impact of influenza.